# Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients

> **NCT00138879** · — · COMPLETED · sponsor: **St Mark's Hospital Foundation** · enrollment: 54 (—)

## Conditions studied

- Crohn's Disease
- Short Bowel Syndrome
- Malabsorption Syndromes
- Celiac Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00138879
- **Lead sponsor:** St Mark's Hospital Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 54 (—)
- **Last updated:** 2005-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00138879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00138879, "Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00138879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*